Streetbeat News

LGMK

LogicMark, Inc.

https://www.logicmark.com

Industry

Security & Protection Services

LogicMark, Inc. offers personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company, through its subsidiary, LogicMark LLC, manufactures and distributes non-monitored and monitored personal emergency response systems sold through healthcare durable medical equipment and monitored security dealers/distributors, and the United States Department of Veterans Affairs. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

LogicMark (NASDAQ:LGMK) is anticipated to report a Q1 2024 EPS of $-1.73 on March 27, 2024. Investors are keen on whether the company will surpass this estimate and provide positive future guidance. Historically, LogicMark's stock price has been sensitive to earnings outcomes and guidance. The stock is currently trading at $1.01, reflecting a 74.62% decline over the last year, indicating investor concern ahead of the earnings report.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 4:02 pm

In Wednesday's after-market session, several healthcare stocks experienced significant movements. Atara Biotherapeutics (ATRA) saw a 24.3% increase, while MoonLake (MLTX) rose by 12.98%. TC BioPharm (TCBP), Perspective Therapeutics (CATX), Lucy Scientific Discovery (LSDI), and Calliditas Therapeutics (CALT) also posted gains. Conversely, Jin Medical International (ZJYL) led the losers with a 10.7% decline, followed by Avalo Therapeutics (AVTX), Eiger BioPharmaceuticals (EIGR), Monogram Orthopaedics (MGRM), LogicMark (LGMK), and Aclarion (ACON) with notable decreases.

Portfolio Pulse from Benzinga Insights

December 20, 2023 | 9:31 pm

Compugen Ltd. (CGEN) shares soared by over 200% after Gilead Sciences announced an exclusive licensing agreement for Compugen's pre-clinical immunotherapy program. Other stocks also moved significantly in Tuesday's mid-day session, with various companies experiencing gains due to positive developments such as FDA approvals, business accreditations, and favorable analyst upgrades. Conversely, some stocks fell sharply due to negative events like pricing of public offerings, discontinuation of joint development programs, and unfavorable patent litigation outcomes.

Portfolio Pulse from Avi Kapoor

December 19, 2023 | 6:34 pm

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Fresh2 Group, Inspire Veterinary, Brainstorm Cell, Leap Therapeutics, Tivic Health Systems, and Immuneering saw their stocks rise by 18.27% to 28.4%. On the other hand, LogicMark, Connect Biopharma Hldgs, NanoString Technologies, MorphoSys, Acutus Medical, and Fortress Biotech faced declines ranging from 21.07% to 42.7%. The movements were accompanied by notable trading volumes, with some companies trading at several times their average full-day volume. MorphoSys's decline followed its Q3 earnings release four days prior.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 5:31 pm

Applied UV, Inc. (AUVI) shares soared by approximately 96% in pre-market trading following the release of their third-quarter results, which showed a reduced loss per share and a significant increase in sales compared to the previous year. The company also reaffirmed its revenue guidance for 2023. Other stocks experienced movement in pre-market trading, with notable gainers including Bruush Oral Care Inc. (BRSH), Blue Star Foods Corp. (BSFC), and Yoshiharu Global Co. (YOSH), among others. Conversely, several companies saw their shares decline, such as Safe and Green Development Corporation (SGD), WANG & LEE GROUP, Inc. (WLGS), and Mural Oncology plc (MURA).

Portfolio Pulse from Lisa Levin

November 20, 2023 | 1:19 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. Altamira Therapeutics (CYTO) saw a 27.7% increase, while Intelligent Bio Solutions (INBS) dropped 30.0%. Other notable gainers include LogicMark (LGMK), TRACON Pharma (TCON), MediciNova (MNOV), and Kronos Bio (KRON). On the losing side, Yield10 Bioscience (YTEN) and Vera Therapeutics (VERA) saw declines of 22.23% and 12.78%, respectively. The movements are reflective of market reactions to various company-specific news and overall market conditions.

Portfolio Pulse from Benzinga Insights

November 20, 2023 | 1:06 pm

LogicMark (NASDAQ:LGMK) reported Q3 2023 GAAP EPS of $(1.10), a 76.09% improvement from $(4.60) YoY. However, sales decreased by 13.99% to $2.37M from $2.75M YoY.

Portfolio Pulse from saritha@benzinga.com

November 09, 2023 | 9:40 pm

The article lists the stocks that gained and lost the most during Friday's mid-day trading session. Among the gainers were Sigma Additive Solutions, Bio-Path Holdings, and Shift Technologies, while the losers included Bellerophon Therapeutics, Outset Medical, and MSP Recovery. The article also mentions several companies that reported better-than-expected earnings, such as Comtech Telecommunications and JPMorgan Chase, and others that lowered their guidance or reported worse-than-expected results, such as Belden and SMART Global Holdings.

Portfolio Pulse from Lisa Levin

October 13, 2023 | 5:14 pm

Shares of several companies including Oblong, Bio-Path Holdings, Blue Star Foods, Versus Systems, RedHill Biopharma, Datasea, Shift Technologies, Getaround, Scienjoy Holding, and Comtech Telecommunications surged in pre-market trading. Comtech's shares rose after posting better-than-expected Q4 results. On the other hand, shares of Cassava Sciences, SMART Global Holdings, BeyondSpring, Edesa Biotech, ReShape Lifesciences, Momentus, LogicMark, Society Pass, Tian Ruixiang Holdings, and ParaZero Technologies fell in pre-market trading.

Portfolio Pulse from Lisa Levin

October 13, 2023 | 11:35 am

During Thursday's intraday session, several healthcare stocks experienced significant movements. Gainers included OpGen (OPGN), Atreca (BCEL), Jaguar Health (JAGX), LogicMark (LGMK), Processa Pharma (PCSA), and Reshape Lifesciences (RSLS). Losers included RVL Pharmaceuticals (RVLP), Tempest Therapeutics (TPST), T2 Biosystems (TTOO), Agape ATP (ATPC), Phio Pharma (PHIO), and PMV Pharma (PMVP).

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 5:37 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.